MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study. Cai X, Lin J, Li C, Xu T, et al. BMC Cancer 2024;24:1384.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cai X, Lin J, Li C, Xu T, et al. MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study. BMC Cancer 2024;24:1384.
PMID: 39528978